Personalis WKN: A2PLTK ISIN: US71535D1063 Forum: Aktien Thema: Hauptdiskussion

https://investors.personalis.com/news-releases/news-release-details/personalis-launches-next-personaltm-tumor-informed-liquid-biopsy

Personalis Reports Third Quarter 2021 Financial Results https://www.businesswire.com/news/home/20211104005284/en/Personalis-Reports-Third-Quarter-2021-Financial-Results

PERSONALIS ANNOUNCES ISSUANCE OF US PATENTS RELATED TO THE EXOME-WIDE NEXT LIQUID BIOPSY PLATFORM https://www.lawyer-monthly.com/2021/10/personalis-announces-issuance-of-us-patents-related-to-the-exome-wide-next-liquid-biopsy-platform/

Das ist doch leider sehr oft so. Sollte sie dann irgendwann mal in paar Jahren auf 50€ gehen kommt ein Artikel in dem es heisst: Wie in der Ausgabe XYZ empfohlen bla bla 😂😂

Noch ein Grund mehr die Finger von diesen Jungs weg zulassen. Das Geld was ich depp in die finanziert habe hätte ich lieber angelegt...

Ignoriert der feine Herr Doepke diese Aktie mit Absicht? :)

Personalis Reports Second Quarter 2021 Financial Results https://www.businesswire.com/news/home/20210804005894/en/Personalis-Reports-Second-Quarter-2021-Financial-Results ... Second Quarter and Recent Highlights • Record quarterly revenue of $21.7 million in the second quarter of 2021 compared with $19.5 million in the second quarter of 2020, an 11% increase • Revenue of $8.2 million from biopharma and all other customers, excluding the U.S. Department of Veterans Affairs Million Veteran Program (VA MVP), in the second quarter of 2021 compared with $4.7 million in the second quarter of 2020, a 72% increase • Ended the second quarter with cash, cash equivalents, and short-term investments of $328.9 million as of June 30, 2021 • Achieved milestone of delivering more than 125,000 whole human genome sequences to the VA MVP ...